Skip to content

Platelet gummi candy effect on the Oral cavity resistant GVHD wounds

Construction of the cord blood allogeneic platelet gummi candy and investigation its effect on the Oral cavity resistant GVHD wounds: A pilot clinical study

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201202049568N4
Enrollment
10
Registered
2021-06-28
Start date
2021-07-23
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral cavity GVHD wounds. Chronic graft-versus-host disease

Interventions

Intervention 1: Intervention group: Seven gummies containing platelet lysates are given to the patient. The patient is instructed on the correct method of consumption by taking one at a specific time

Sponsors

Omid charity
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 12 Years

Inclusion criteria

Inclusion criteria: The patient has GVHD after allogeneic hematopoietic stem cell transplantation At least 100 days must have passed since the patient was transplanted Age range between 2 to 12 years

Exclusion criteria

Exclusion criteria: Other systemic disorders such as severe cardiovascular diseases Patients who had lesions with dysplasia Patients who received topical treatments in the last 2 weeks Patients receiving therapy with anticoagulants

Design outcomes

Primary

MeasureTime frame
Wound size, amount of pain and burning in the mouth. Timepoint: 3 Months. Method of measurement: Direct wound observation , Numerical Rating score of Pain, graded from 0 to 10, were 0 is no pain at all and 10 represent severe pain, obtaining lower values reflects improvement.

Secondary

MeasureTime frame
Remission time. Timepoint: 3 months. Method of measurement: Time until flare up of the disease occur using a binary scale (Stable/Not stable) described by Conrotto et al., 2006.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRashin Mohseni

Tehran University of Medical Sciences

rashin_mohseni@yahoo.com+98 21 6694 8444

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026